Aquestive Therapeutics AQST
NASDAQ AQST
$4.68 -0.07 (-1.58%)
As of: Sep 29, 2026 · 3:59 PM EDT

Aquestive Therapeutics (AQST) Enterprise Value (2018 - 2026)

Updated

Aquestive Therapeutics (AQST) posted Enterprise Value of $423.64 million for Q2 2026, up 57.9% from $268.32 million a year earlier and up 4.6% from the prior quarter.

Analysis

Aquestive Therapeutics (AQST) Enterprise Value (2018 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Enterprise Value at Aquestive Therapeutics was $62.67 million, up 24.8% year-over-year; for FY2025, it was $667.24 million, up 162.8% from FY2024.

  • Annual Enterprise Value has increased for three consecutive years, with a five-year compound annual growth rate of 34.2% (FY2020 to FY2025).
  • In prior years, Aquestive Therapeutics' Enterprise Value was $253.89 million in FY2024 (+121.6%), $114.56 million in FY2023 (+419.1%), $22.07 million in FY2022 (-83.3%) and $132.36 million in FY2021 (-13.6%).
  • Quarterly Enterprise Value has run from a low of $16.45 million in Q2 2022 to a high of $667.24 million in Q4 2025 over five years.
  • On a year-over-year basis, Enterprise Value has increased in each of the last 13 quarters, with growth averaging 118.0% over the last eight quarters.
  • The strongest year-over-year quarter for Enterprise Value in the past five years was Q1 2024, with growth of 492.4%; the weakest was Q2 2022, with a decline of 86.2%.
  • According to Business Quant data, Enterprise Value for the three prior quarters was $405.05 million (Q1 2026), $667.24 million (Q4 2025) and $551.01 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Aquestive Therapeutics 596.18 Mn 136.72 Mn 9.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 423.64 Mn
Mar 31, 2026 405.05 Mn
Dec 31, 2025 667.24 Mn
Sep 30, 2025 551.01 Mn
Jun 30, 2025 268.32 Mn
Mar 31, 2025 219.36 Mn
Dec 31, 2024 253.89 Mn
Sep 30, 2024 376.17 Mn
Jun 30, 2024 146.89 Mn
Mar 31, 2024 218.40 Mn
Dec 31, 2023 114.56 Mn
Sep 30, 2023 77.20 Mn
Jun 30, 2023 79.23 Mn
Mar 31, 2023 36.87 Mn
Dec 31, 2022 22.07 Mn
Sep 30, 2022 44.36 Mn
Jun 30, 2022 16.45 Mn
Mar 31, 2022 93.89 Mn
Dec 31, 2021 132.36 Mn
Sep 30, 2021 143.60 Mn
API Access

Aquestive Therapeutics Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=AQST&period=max&api_key=YOUR_API_KEY